Abstract
Acetyl-l-carnitine (ALC), the acetyl ester of l-carnitine, is a naturally occurring molecule which plays an essential role in intermediary and mitochondrial metabolism. It has also neurotrophic and antioxidant actions, demonstrating efficacy and high tolerability in the treatment of neuropathies of various etiologies. ALC is a molecule of considerable interest for its clinical application in various neural disorders, although little is known regarding its effects on gene expression. Suppression subtractive hybridization methodology was used for the generation of subtracted complementary DNA libraries and the subsequent identification of differentially expressed transcripts in the rat brain after chronic ALC treatments. We provided evidence for a downregulation of the expression of all of the isoforms of myelin basic protein gene following prolonged ALC treatment, indicating a possible role in the modulation of myelin basic protein turnover, stabilizing and maintaining myelin integrity.
Similar content being viewed by others
References
Jones LL, McDonald DA, Borum PR (2010) Acylcarnitines: role in brain. Prog Lipid Res 49(1):61–75
Barhwal K, Singh SB, Hota SK, Jayalakshmi K, Ilavazhagan G (2007) Acetyl-l-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats. Eur J Pharmacol 570(1–3):97–107
Traina G, Federighi G, Brunelli M (2008) Up-regulation of kinesin light-chain 1 gene expression by acetyl-l-carnitine: therapeutic possibility in Alzheimer’s disease. Neurochem Int 53:244–247
Calabrese V, Cornelius C, Mancuso C et al (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33(12):2444–2471
Calò LA, Pagnin E, Davis PA et al (2006) Antioxidant effect of l-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 107:54–60
Ando S, Tadenuma T, Tanaka Y et al (2001) Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. Neurosci Res 66:266–271
Traina G, Valleggi S, Bernardi R et al (2004) Identification of differentially expressed genes induced in the rat brain by acetyl-l-carnitine as evidenced by suppression subtractive hybridisation. Mol Brain Res 132:57–63
Mathisen PM, Pease S, Garvey J, Hood L, Readhead C (1993) Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 90:10125–10129
Traina G, Bernardi R, Cataldo E et al (2008) In the rat brain acetil-l-carnitine treatment modulates the expression of gene involved in neuronal ceroid lipofuscinosis. Mol Neurobiol 38(2):146–152
Kimura M, Sato M, Akatsuka A et al (1998) Overexpression of a minor component of myelin basic protein isoform (17.2 kDa) can restore myelinogenesis in transgenic shiverer mice. Brain Res 785:245–252
Staugaitis SM, Colman DR, Pedraza L (1996) Membrane adhesion and other functions for the myelin basic proteins. Bioessay 18(1):13–18
Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81(2):871–927
Readhead C, Popko B, Takahashi N et al (1987) Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 48(4):703–712
Roaoach A, Boyland K, Horvath S, Prusiner SB, Hood LE (1983) Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34(3):799–806
Zhang QY, Huang JH, Li HZ et al (2008) Myelin-basic protein-reactive specific CD4+ and CD8+ NK lymphocytes induce morphological changes in neuronal cell bodies and myelin sheaths: implications for multiple sclerosis. Arch Med Res 39(1):45–51
Lamers KJ, Vos P, Verbeek MM et al (2003) Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull 61:261–264
Ikeda O, Murakami M, Ino H et al (2002) Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression. J Neuropathol Exp Neurol 61(2):142–153
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Traina, G., Federighi, G., Macchi, M. et al. Modulation of Myelin Basic Protein Gene Expression by Acetyl-l-Carnitine. Mol Neurobiol 44, 1–6 (2011). https://doi.org/10.1007/s12035-011-8189-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-011-8189-x